TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,994 | -68.6% | 24,760 | -6.7% | 0.00% | -66.7% |
| Q2 2023 | $659,303 | +69.2% | 26,542 | +2.4% | 0.00% | +50.0% |
| Q1 2023 | $389,732 | +42.9% | 25,913 | +12.4% | 0.00% | +100.0% |
| Q4 2022 | $272,788 | +102.1% | 23,059 | +0.8% | 0.00% | 0.0% |
| Q3 2022 | $135,000 | +13400.0% | 22,865 | +8528.3% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 265 | -35.7% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 412 | +312.0% | 0.00% | – |
| Q4 2021 | $2,000 | -50.0% | 100 | -9.9% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 111 | -6.7% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 119 | -4.8% | 0.00% | – |
| Q1 2021 | $6,000 | -87.0% | 125 | -85.9% | 0.00% | -100.0% |
| Q4 2020 | $46,000 | +84.0% | 885 | -5.3% | 0.00% | – |
| Q3 2020 | $25,000 | +66.7% | 935 | +27.2% | 0.00% | – |
| Q2 2020 | $15,000 | +400.0% | 735 | +22.5% | 0.00% | – |
| Q3 2019 | $3,000 | -40.0% | 600 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |